1. Kemper AR, Newman TB, Slaughter JL, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3):e2022058859.
2. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6-14.
3. Academy Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
4. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant 35 weeks’ gestation: an update with clarifications. Pediatrics 2009;124:1193-8.
5. Bahr TM, Henry E, Christensen RD, Minton SD, Bhutani VK. A New Hour-Specific Serum Bilirubin Nomogram for Neonates ≥ 35 Weeks of Gestation. The Journal of Pediatrics 2021;236:28-33.
6. Marcdante K, Kliegman RM. Nelson Essentials of Pediatrics 8th Edition. 2018; Chapter 5: Growth and Development.
7. Kleinman K, McDaniel L, Molloy M. The Harriet Lane Handbook 22nd Edition. 2021; Chapter 21: Nutrition and Growth.
8. Jones SG, Samanta D. Macrocephaly. 2024; StatPearls Publishing; Jul 24.
9. American Academy of Pediatrics. Red Book. 2021-2024: Report of the Committee on Infectious Disease. 32nd Edition.